Bristol Myers Squibb is seeking a Director of Bioconjugation to lead a science-driven portfolio across ADC and ARC/AOC platforms. The role requires building platform capabilities, leading a team of bioconjugation scientists, and partnering with Cross-functional teams to drive conjugation strategy from target selection to development.
Ideal candidates have extensive experience in conjugation chemistry, payload design, and managing discovery programs, with strong communication and external
#J-18808-LjbffrDirector of Bioconjugation & ADC Platform Strategy in virginia at Unknown Company
This position is listed as full time and onsite.